Astal Laboratories Limited (BOM:512600)
India flag India · Delayed Price · Currency is INR
84.58
+2.54 (3.10%)
At close: Jul 31, 2026

Astal Laboratories Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
2,4732,473636.55236.536.072.11
Revenue Growth
288.52%288.52%169.15%555.71%1611.01%3.80%
Operating Income
177.3177.3119.7810.870.32-0.12
Net Income
147.09147.0989.257.850.16-0.17
Earnings Per Share
4.314.318.041.550.04-0.04
EPS Growth
-46.41%-46.41%417.71%3689.19%--

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
13.0113.0117.360.770.840.18
Total Debt
498.93498.93132.683.12--
Net Cash (Debt)
-485.92-485.92-115.3857.640.840.18
Net Cash Growth
---6729.74%361.20%-41.52%
Net Cash Per Share
-14.24-14.24-10.4011.410.210.05

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-176.99-176.99-125.17-55.79-14.37-2.49
Capital Expenditures
-13.93-13.93-57.75-59.17--
Free Cash Flow
-190.91-190.91-182.92-114.96-14.37-2.49
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Margin
7.17%7.17%18.82%4.59%0.89%-5.74%
Pretax Margin
7.17%7.17%18.82%4.59%0.89%-8.06%
Profit Margin
5.95%5.95%14.02%3.32%0.46%-8.11%
FCF Margin
-7.72%-7.72%-28.74%-48.61%-39.83%-118.03%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
19.6218.768.3751.21720.07-
PS Ratio
1.491.121.171.703.2730.52